Your browser doesn't support javascript.
loading
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
Miller, William C; Hoffman, Irving F; Hanscom, Brett S; Ha, Tran V; Dumchev, Kostyantyn; Djoerban, Zubairi; Rose, Scott M; Latkin, Carl A; Metzger, David S; Lancaster, Kathryn E; Go, Vivian F; Dvoriak, Sergii; Mollan, Katie R; Reifeis, Sarah A; Piwowar-Manning, Estelle M; Richardson, Paul; Hudgens, Michael G; Hamilton, Erica L; Sugarman, Jeremy; Eshleman, Susan H; Susami, Hepa; Chu, Viet Anh; Djauzi, Samsuridjal; Kiriazova, Tetiana; Bui, Duong D; Strathdee, Steffanie A; Burns, David N.
Afiliação
  • Miller WC; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA. Electronic address: miller.8332@osu.edu.
  • Hoffman IF; Division of Infectious Diseases, School of Medicine, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hanscom BS; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ha TV; Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; UNC Vietnam, Yen Hoa, Cau Giay District, Hanoi, Vietnam.
  • Dumchev K; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
  • Djoerban Z; Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Rose SM; Science Facilitation Department, FHI 360, Durham, NC, USA.
  • Latkin CA; Department of Health Policy and Management, Johns Hopkins University, Baltimore, MA, USA.
  • Metzger DS; HIV Prevention Research Division, Department of Psychiatry, School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Lancaster KE; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
  • Go VF; Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Dvoriak S; Academy of Labor, Social Relations and Tourism, Kyiv, Ukraine.
  • Mollan KR; Center for AIDS Research, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Reifeis SA; Center for AIDS Research, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Piwowar-Manning EM; Bloomberg School of Public Health and Department of Pathology, Johns Hopkins University, Baltimore, MA, USA.
  • Richardson P; Bloomberg School of Public Health and Department of Pathology, Johns Hopkins University, Baltimore, MA, USA.
  • Hudgens MG; Center for AIDS Research, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hamilton EL; Science Facilitation Department, FHI 360, Durham, NC, USA.
  • Sugarman J; Berman Institute of Bioethics and Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MA, USA.
  • Eshleman SH; Bloomberg School of Public Health and Department of Pathology, Johns Hopkins University, Baltimore, MA, USA.
  • Susami H; Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Chu VA; UNC Vietnam, Yen Hoa, Cau Giay District, Hanoi, Vietnam.
  • Djauzi S; Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
  • Kiriazova T; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
  • Bui DD; Vietnam Administration of HIV/AIDS Control, Hanoi, Vietnam.
  • Strathdee SA; Department of Medicine, School of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Burns DN; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MA, USA.
Lancet ; 392(10149): 747-759, 2018 09 01.
Article em En | MEDLINE | ID: mdl-30191830
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Abuso de Substâncias por Via Intravenosa / Carga Viral / Terapia Antirretroviral de Alta Atividade / Tratamento de Substituição de Opiáceos Tipo de estudo: Clinical_trials / Incidence_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia / Europa Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Abuso de Substâncias por Via Intravenosa / Carga Viral / Terapia Antirretroviral de Alta Atividade / Tratamento de Substituição de Opiáceos Tipo de estudo: Clinical_trials / Incidence_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia / Europa Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article